Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

ALSE

Alseres Pharmaceuticals (CE) (ALSE)

Alseres Pharmaceuticals Inc (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:ALSE
DateTimeSourceHeadlineSymbolCompany
11/21/20143:10PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
11/18/20142:09PMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
08/14/20147:09AMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
05/23/201412:04PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
05/16/20148:46AMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
04/10/20147:52AMEdgar (US Regulatory)Annual Report (10-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
03/31/20144:00PMEdgar (US Regulatory)Quarterly Schedule of Portfolio Holdings of Registered Management Investment Company (n-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
03/31/20144:00PMEdgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
07/31/20137:29AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
05/17/20131:47PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
05/16/20131:44PMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
04/01/201312:23PMEdgar (US Regulatory)Annual Report (10-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
02/21/20132:05PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
02/07/20137:03AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
01/28/20131:40PMEdgar (US Regulatory)Definitive Materials Filed by Investment Companies. (497)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
01/28/20131:40PMEdgar (US Regulatory)Annual Report (management Company) (nsar-b)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
01/28/20131:37PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
01/28/201311:40AMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
01/08/20139:21AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
01/08/20139:21AMEdgar (US Regulatory)Current report filing (8-K)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
11/14/20125:08AMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
11/14/20125:08AMEdgar (US Regulatory)Quarterly Report (10-Q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
08/13/20125:16AMEdgar (US Regulatory)Quarterly Report (10-Q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
07/23/20125:02AMEdgar (US Regulatory)Current report filing (8-K)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
07/02/20127:30AMEdgar (US Regulatory)Current report filing (8-K)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
06/13/20129:06AMEdgar (US Regulatory)Current report filing (8-K)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
05/11/20122:18PMEdgar (US Regulatory)Quarterly Report (10-Q)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
05/08/20123:12PMEdgar (US Regulatory)Current report filing (8-K)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
03/29/20123:50PMEdgar (US Regulatory)Annual Report (10-K)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
03/19/20122:50PMEdgar (US Regulatory)Current report filing (8-K)USOTC:ALSEAlseres Pharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:ALSE